Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

NRSN Financial Statements and Analysis

NASDAQ : NRSN

NeuroSense Therapeutics Ltd.

$1.09
-0.01-0.91%
At Close 4:00 PM
$1.08
-0.01-0.92%
After-Market 04:48 PM
50
BESG ScoreESG Rating

NRSN FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

NRSN Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue00000
gross profit00000
gross profit ratio00000
research and development expenses1.161M1.569M1.882M1.958M1.625M
general and administrative expenses946.00K1.461M1.112M1.329M1.272M
selling and marketing expenses00000
selling general and administrative expenses946.00K1.461M1.112M1.329M1.272M
other expenses00000
operating expenses2.107M3.03M2.994M3.287M2.897M
cost and expenses2.107M3.03M2.994M3.287M2.897M
interest income02.173M0-3.715M3.693M
interest expense002.41M-2.197M2.202M
depreciation and amortization005.25K-1.86M5.883M
ebitda-2.107M-3.03M-2.994M-5.147M2.986M
ebitda ratio00000
operating income-2.107M-3.03M-2.994M-3.287M-2.897M
operating income ratio00000
total other income expenses net-41.00K2.173M-2.41M336.999K3.681M
income before tax-2.148M-857.00K-5.404M-2.95M784.00K
income before tax ratio00000
income tax expense00-43.276K-1.000
net income-2.148M-857.00K-5.404M-2.95M784.00K
net income ratio00000
eps-0.12-0.048-0.35-0.190.058
eps diluted-0.12-0.048-0.35-0.190.058
weighted average shs out18.055M18.055M15.405M15.379M13.623M
weighted average shs out dil18.055M18.055M15.405M15.379M13.623M
Graph

NRSN Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents344.00K1.208M771.00K2.68M4.759M
short term investments035.00K000
cash and short term investments344.00K1.243M771.00K2.68M4.759M
net receivables406.00K376.00K421.00K166.00K309.00K
inventory00-457.00K00
other current assets35.00K0070.00K0
total current assets785.00K1.619M1.192M2.916M5.105M
property plant equipment net176.00K200.00K231.00K238.00K260.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments0023.00K22.00K21.00K
tax assets00000
other non current assets23.00K22.00K000
total non current assets199.00K222.00K254.00K260.00K281.00K
other assets00000
total assets984.00K1.841M1.446M3.176M5.386M
account payables1.392M1.483M2.384M1.459M913.00K
short term debt00069.00K0
tax payables00000
deferred revenue00000
other current liabilities2.391M2.025M2.151M1.931M1.896M
total current liabilities3.783M3.508M4.535M3.459M2.809M
long term debt19.00K36.00K55.00K73.00K84.00K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities003.849M1.518M2.689M
total non current liabilities19.00K36.00K3.904M1.591M2.773M
other liabilities0001.000
capital lease obligations19.00K36.00K55.00K73.00K84.00K
total liabilities3.802M3.544M8.439M5.05M5.582M
preferred stock00000
common stock00000
retained earnings-34.53M-32.382M-31.525M-32.066M-29.116M
accumulated other comprehensive income loss0024.532M30.192M28.92M
other total stockholders equity31.712M30.679M24.532M00
total stockholders equity-2.818M-1.703M-6.993M-1.874M-196.00K
total equity-2.818M-1.703M-6.993M-1.874M-196.00K
total liabilities and stockholders equity984.00K1.841M1.446M3.176M5.386M
minority interest00000
total investments022.00K23.00K22.00K21.00K
total debt19.00K36.00K55.00K142.00K84.00K
net debt-325.00K-1.172M-716.00K-2.538M-4.675M
Graph

NRSN Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-03-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSD
calendar year2024202320232023
periodQ1Q3Q2Q1
deferred income tax0000
stock based compensation001.784K0
change in working capital0000
accounts receivables0000
inventory0000
accounts payables0000
other working capital0000
other non cash items5.404K-784.00K5.225K3.889K
net cash provided by operating activities001.784K0
investments in property plant and equipment0000
acquisitions net0000
purchases of investments0000
sales maturities of investments0000
other investing activites0000
net cash used for investing activites0000
debt repayment0000
common stock issued0000
common stock repurchased0000
dividends paid0000
other financing activites0000
net cash used provided by financing activities0000
effect of forex changes on cash0000
net change in cash0-2.331M5.729M-2.181M
cash at end of period04.796M7.127M1.398M
cash at beginning of period07.127M1.398M3.579M
operating cashflow001.784K0
capital expenditure0000
free cash flow001.784K0
Graph

Frequently Asked Questions

How did NeuroSense Therapeutics Ltd. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, NRSN generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did NeuroSense Therapeutics Ltd. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. NeuroSense Therapeutics Ltd. reported a $0.00 Gross Profit for the quarter ended Mar 31, 2024.

Have NRSN's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. NRSN incurred $2.11M worth of Operating Expenses, while it generated -$2.11M worth of Operating Income.

How much Net Income has NRSN posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from NeuroSense Therapeutics Ltd., the company generated -$2.15M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did NeuroSense Therapeutics Ltd. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to NeuroSense Therapeutics Ltd. as of the end of the last quarter was $344.00K.

What are NRSN's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, NRSN had Total Net Receivables of $406.00K.

In terms of Total Assets and Current Assets, where did NeuroSense Therapeutics Ltd. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of NRSN were $785.00K, while the Total Assets stand at $984.00K.

As of the last quarter, how much Total Debt did NeuroSense Therapeutics Ltd. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of NRSN's debt was $19.00K at the end of the last quarter.

What were NRSN's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, NRSN reported total liabilities of $3.80M.

How much did NRSN's Working Capital change over the last quarter?

Working Capital Change for NRSN was $0.00 over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

NRSN generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. NRSN generated $0.00 of Cash from Operating Activities during its recently reported quarter.

What was NRSN's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. NRSN reported a $0.00 Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph